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Abstract
Orthostatic intolerance, one of the principle causes of syncope, can occur secondary to con-
comitant venous pooling and enhanced capillary filtration. We aimed to evaluate a prototype
portable calf active compression brace (ACB) designed to improve orthostatic haemody-
namic control. Fourteen healthy volunteers participated in a randomized, placebo controlled,
cross-over, double-blind study. Testing consisted of head-upright tilting and walking on a
treadmill conducted on two consecutive days with a pair of ACBs wrapped around both
calves. The ACB was actuated on one test day, but not on the other (placebo). Wearability,
comfort, and ambulatory use of the ACB were assessed using questionnaires. The average
calf pressure exerted by the ACB was 46.3±2.2 mmHg and the actuation pressure was 20.7
±1.7 mmHg. When considering the differences between ACB actuation and placebo during
tilt after supine rest there were trends for a larger stroke volume (+5.20±2.34%, p = 0.05)
and lower heart rate (-5.12±2.41%, p = 0.06) with ACB actuation, with no effect on systolic
arterial pressure (+4.86±3.41%, p = 0.18). The decrease in stroke volume after ten minutes
of tilting was positively correlated with the height:calf circumference (r = 0.464; p = 0.029;
n = 22; both conditions combined). The increase in heart rate after ten minutes of tilting was
negatively correlated with the height:calf circumference (r = -0.485; p = 0.022; n = 22; both
conditions combined) and was positively correlated with the average calf circumference (r =
0.539; p = 0.009; n = 22; both conditions combined). Participants reported good ACB wear-
ability and comfort during ambulatory use. These data verify that the ACB increased stroke
volume during tilting in healthy controls. Active calf compression garments may be a viable
option for the management of orthostatic intolerance.
New & noteworthy
We performed a randomised, placebo controlled trial to evaluate the efficacy of an innovative
active compression brace (ACB) to improve orthostatic haemodynamic control in fourteen
healthy volunteers. The wearability, comfort, and ambulatory use of the device were also
PLOS ONE | https://doi.org/10.1371/journal.pone.0187885 November 22, 2017 1 / 23
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation:Moein H, Jhalli R, Blaber AP, Claydon VE,
Menon C (2017) Evaluating the efficacy of an active
compression brace on orthostatic cardiovascular
responses. PLoS ONE 12(11): e0187885. https://
doi.org/10.1371/journal.pone.0187885
Editor: Tatsuo Shimosawa, The University of
Tokyo, JAPAN
Received: July 5, 2017
Accepted:October 28, 2017
Published: November 22, 2017
Copyright: © 2017 Moein et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: "Due to legal and
ethical restriction, data cannot be made publicly
available. Data will be made available upon request;
however, only aggregated data may be in the public
domain according to the stipulations from our
research ethics board with respect to the
maintenance of confidentiality. Additional published
or public analyses would only be permitted with
ethics approval for secondary data access, and
only with aggregated analyses. Requests can be
sent to Dina Shafey, Associate Director, Office of
Research Ethics, Simon Fraser University
(dshafey@sfu.ca). The Simon Fraser University
evaluated. Device actuation enhanced stroke volume and reduced orthostatic tachycardia. Par-
ticipants reported good ACB wearability and comfort ratings during ambulatory use. Active
calf compression garments may be a viable option for the management of orthostatic
intolerance.
Compression therapy  Active compression brace  Shape memory alloys Orthostatic intol-
erance  Syncope.
Introduction
Syncope, or fainting, refers to a transient loss of consciousness and postural tone that typically
occurs when upright and is associated with reduced cerebral blood flow [1,2]. The principal
causes of syncope are classified as reflex (neutrally-mediated), cardiac (cardiovascular) and
syncope due to orthostatic hypotension (OH) [3]. OH has been defined by consensus as a fall
in systolic arterial pressure (SAP) of at least 20 mmHg and/or diastolic arterial pressure
(DAP) of at least 10 mmHg within 3 minutes of standing [4,5]. Patients suffering from OH
may feel dizzy, weak or faint upon standing due to an excessive fall in cardiac output (CO) or
inadequate vasoconstrictor mechanisms [4,5]. Approximately 30% of all instances of syncope
are due to OH, affecting 5% to 11% of the middle-aged adult population and 15% to 30% of
individuals aged 65 years and older [6,7]. In patients with OH, applying external compression
to the lower limbs or abdomen might diminish venous pooling and capillary filtration, and so
assist venous return and the maintenance of CO [3,8–11].
Static external compression stockings are commonly recommended for the management of
syncope. They are prescribed for those suffering from orthostatic intolerance, where the exter-
nal counter-pressure of the lower limbs or abdomen can reduce venous pooling and capillary
filtration, thus increase venous return [9,12]. Garments that compress the abdomen have
shown greater efficacy compared to calf compression stockings in the prevention of orthostatic
intolerance [8,11,13,14]. However, they are reported to be uncomfortable, hard to put on and
remove, and are associated with poor patient compliance [15,16]. For this reason, much of the
recent focus on compression garments has been on calf compression. Undoubtedly, pooling
and filtration in the legs can be significant, with 500 ml of blood accumulation in the static calf
within just 10 minutes of 60˚ head-upright tilting [17]. However, the efficacy of static calf com-
pression stockings in the management of orthostatic intolerance has been challenged [18]. On
the other hand, intermittent pneumatic pressure pumps have shown strong potential for the
improvement of orthostatic tolerance. They have been shown to improve arterial flow, increas-
ing venous outflow from the lower limbs, venous blood flow velocity and venous pressure [19–
22]. However, they restrict patient mobility and are not portable. Considering the concerns
raised regarding the poor efficacy and suitability of current compression garments, we believe
there is a need for novel ambulatory compression devices that provide the desired haemody-
namic benefit for the patients, are comfortable and wearable, and can produce intermittent
pressure.
We recently developed an active compression brace (ACB) for the calf that utilizes artificial
muscle technology. This ACB has been prototyped using smart alloy technology and its perfor-
mance has previously been investigated in vitro [23]. Specifically, shape memory alloy (SMA)
wires were used as actuators in the ACB and produce pressure when actuated. SMAs, includ-
ing NiTi wires, are a group of metallic alloys that exhibit the characteristics of either large
recoverable strains or large force due to temperature and/or load changes. NiTi is one of the
most studied SMAs and is commercially available [24,25]. NiTi wires can have high force per
unit area (exceeding 200 MPa), and can be actuated using Joule heating via an applied current
[25]. The prototyped ACB can be wrapped around the calf area of the leg and applies
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adjustable initial pressure similar to medical compression stockings using a Boa closure system
[26] (Fig 1). The pressure can then be increased by increasing the electrical current applied to
the SMA wires.
In this study, we aimed to evaluate the efficacy of the ACB for the improvement of stroke
volume (SV) and cardiovascular hemodynamics during orthostatic stress using a randomised
placebo-controlled double-blind crossover design. We compared responses with the device
activated and with it wrapped but actuation pressure not applied (placebo). We measured the
compression on the calves exerted by the ACB and obtained cardiovascular and lower limb cir-
cumference changes through beat-to-beat blood pressure monitoring, electrocardiography
(ECG), and leg strain gauge plethysmography. We hypothesized that during orthostasis the
actuated ACB would reduce the leg volume change, and increase venous return, with an asso-
ciated increase in SV and decrease in heart rate (HR). We also evaluated the effect of walking
on the compression pressures applied, as well as on calf volume changes and cardiovascular
responses. Finally, we evaluated the ACB viability, comfort and wearability during ambulation
based on participant surveys.
Methods
Ethics approval
After the details and procedures of the study had been fully explained to them, all participants
gave written informed consent to participate. This study received ethical approval from the
Simon Fraser University Office of Research Ethics for all measurements (study #2014s0590).
All investigations were performed in association with the Declaration of Helsinki of the World
Medical Association.
Study design
Fourteen adults (four females; aged 27.9±1.3 years) were recruited for this study. Participants
completed a brief medical history; all volunteers were healthy and free of cardiovascular and
neurological disease. None of the participants were taking any medication. Each participant
completed testing on two consecutive days with a pair of ACBs wrapped around both legs. The
ACB was not actuated on one testing, and it was actuated on the other testing. The ACBs were
Fig 1. Active compression brace (ACB). The ACB consisted of thin layer of Teflon on top of a protective layer
of Neoprene as the body of the brace and SMA wires as the actuators. The 3D printed guides and fixtures with
the Boa closure systems, placed at the end of the brace, are also shown in the figure.
https://doi.org/10.1371/journal.pone.0187885.g001
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placed around the widest part of the calf. The wrapping pressure was adjusted to 15 mmHg in
the supine resting position. For the test where we had the ACB actuated, an electrical current
of 180 mA per SMA wires was applied to each of the ACBs. Testing was conducted in a rando-
mised double-blind fashion, at the same time of day. Female participants were tested in the
same phase of their menstrual cycle by testing on consecutive days. Participants were asked to
refrain from strenuous exercise for twelve hours prior to each test, eat a light breakfast, and
avoid caffeine on the morning of each test.
Prior to testing, anthropometric measures were taken. Circumference and skinfold thick-
ness of the calf were determined at the widest section of the calf. Calf cross-sectional area
(cm2) was estimated from the circumference (cm), assuming circularity [27]:
Calf cross sectional area ¼ calf circumference2=4p ð1Þ
Measurements of circumference and skinfold thickness (cm) were used to estimate adipose
tissue cross-sectional area (subcutaneous adipose tissue only):
Adipose tissue cross sectional area ¼ ðCalf cross sectional area  skinfold thicknessÞ=2 ð2Þ
Muscle cross-sectional areas, also assumed to be circular, were estimated by the difference
between cross sectional of areas of the whole limb and adipose tissue with an assumed cross-
section of bone with its constituent marrow (6 cm2) [27]:
Muscle cross sectional area
¼
calf circumference2
4p
 
Calf cross sectional area  skinfold thickness
2
  6ð3Þ
Test protocol
Fig 2 shows the test protocol conducted on each test day. The test consisted of supine rest,
head-upright tilting and walking on a treadmill. Participants initially had twenty minutes of
supine rest. Then, the ACBs were wrapped and set to 15 mmHg applied compression. Accord-
ing to our randomisation protocol, the ACB was either kept not actuated or was actuated for
each test day. If the ACBs were actuated they applied higher compression. The participants
stayed in the supine position (baseline) for seven more minutes. After twenty seven minutes of
supine, participants were head-up tilted (HUT) to 70˚, for ten minutes (HUT1). This was fol-
lowed by walking on a treadmill at a speed of 26.8 m/min (1 mph) for five minutes (walk).
Then, participants stepped back on the tilt-table and were head-upright tilted for a further ten
minutes (HUT2). Finally, they were tilted back to the supine position for five minutes of
Fig 2. Test protocol. The method of randomisation used in the tests was the true random service [28].
https://doi.org/10.1371/journal.pone.0187885.g002
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recovery. The test was terminated if either: their systolic blood pressure fell below 80 mmHg;
their HR was less than 50 bpm or greater than 180 bpm; they experienced presyncopal symp-
toms such as light-headedness, nausea, perspiration and warmth; or the entire protocol was
completed. At test termination, the tilt table was rapidly returned to the supine position [18].
Instrumentation
Active compression brace. The prototyped ACB is shown in Fig 1. Smart material tech-
nology, specifically SMAs, were utilized in the ACB design as the actuator. The SMA wires that
were selected were 102 μm diameter low temperature Flexinol actuator wires (Dynalloy, Inc.
Irvine, California, USA). The fabricated ACB also included a Boa closure system with a steel
lace. The Boa system (Boa Technology Inc. Denver, Colorado, USA), shown in Fig 1, was
placed at the two ends of the brace to fasten the ACB, which had negligible strain when ten-
sioned. The ACB consisted of a thin layer of Teflon on top of a protective layer of Neoprene
(forming the body of the brace) with SMA wires as the actuators. The 3D printed guides and
fixtures held the SMA wires in place. The wires were fixed at the end of the brace by small
washers and a conductive plate for electrical connection. The detailed conceptual design of the
ACB is described in our previous works [23,29]
As an electrical current was applied to the SMA wires of the ACB, their module of elasticity
increased and started to reduce in length–this in turn exerted a pressure on the calf via the Tef-
lon sheet. Pressure exertion from the ACB consisted of two components: mechanical pressure
and actuation pressure. Themechanical pressure was the initial pressure produced by wrapping
the ACB around the leg firmly and fastening the Boa lace, which provided initial stress to the
SMA wires. The actuation pressure resulted from the SMA wires when a current was applied to
them. The total pressure exerted by the ACB on the calf was determined by summing the two
components–mechanical pressure and actuation pressure–together.
Two PicoPress (MediGroup Australia Pty Ltd, Melbourne, Australia) pressure sensors were
used to continuously measure the pressure exerted on both legs by the ACBs. A thin circular
probe was attached to the pressure sensor. The probes were placed between the ACB and the
calves of the participant at the center of the ACB, which was positioned over the maximal cir-
cumference of the calves.
The experimental setup included a driver circuit, which was coupled to a data acquisition
system (DAQ) and a developed LabVIEW software, to pass the required current through to
the ACB and receive the measurement signal. All signals were recorded using a NI 9205 analog
input module (National Instruments, Austin, Texas, USA). The LabVIEW code performed
multiple functions: it measured and recorded the applied current of the ACB, it determined
the required voltage to be applied based on the test protocol at specific timing during the tests,
it recorded the beat-to-beat arterial pressure signals, and it measured and recorded the cali-
brated strain-gauges plethysmography data.
Using this experimental approach, we were able to continuously target, and measure, the
mechanical and actuation pressures. The pressure exerted by the ACB on the underlying Pico-
Press sensor was visualized using the PicoPress program. The ACB was then adjusted through
the Boa system until the pressure while the limb was in a relaxed stationary supine position was
consistent at 15mmHg. This pressure was considered to be the applied mechanical pressure,
and would be subject to change in different phases during the muscle movement. For tests
where the ACB was actuated, the actuation pressure was regulated by applying an electrical cur-
rent of 3.6±0.08 A (180±4 mA per SMA wires), achieved by altering the output voltage to the
ACBs using the DAQ and the LabVIEW program through the driver circuits. This applied cur-
rent was the same for all participants, and was kept constant throughout the test. This means
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that the actuation pressure might be different for different shapes and compliances of the partic-
ipants’ legs, and might change in different phases of the test (for example due to alterations in
the heat loss rate for the SMA wires). It should also be noted that the actuation pressure is
mainly result of an increase in the elastic modulus of the SMA wires due to the martensite to
austenite phase transformation. For these reasons, we measured mechanical and actuation pres-
sures throughout testing for each participant and present these data as group means.
Hemodynamic monitoring. Throughout testing we continuously recorded non-invasive
beat-to-beat finger arterial pressure (Portapres, Finapres Medical Systems, Amsterdam, the
Netherlands), which is based on photoplethysmography. The finger cuff was placed on the
middle phalanx of the middle finger on the left hand. Alterations in finger pressure imposed
by changes in the position of the hand with respect to heart level were compensated using the
in-built height correction system. Continuous internal calibration was also conducted using
the in-built Physiocal algorithm. Changes in CO and SV were also calculated from the
recorded finger arterial pressure with the Beatscope software (Finapres) using the Modelflow
technique [30]. This has been validated for evaluation of changes relative to baseline measure-
ments [31], but without calibration against established techniques such as thermodilution,
absolute values are not comparable [32]. Thus, we only report changes in these variables.
HR and rhythm were monitored using a lead II ECG; (Finapres ECGModule, Finapres
Medical Systems, Amsterdam, the Netherlands).
For our primary outcome measures of SV and SAP we also quantified the orthostatic bur-
den during the two tilted portions, as the area under the curve (AUC) of the response during
the entire phase (excluding the first 25 and last 35 seconds of each phase where data may be
less stable). AUC were calculated as the difference between the baseline parameter (the average
of the first 20 seconds of the final 35 seconds before the end of baseline phase) and the values
for each second of the test multiplied by the time.
We also determined limb volume changes using strain-gauge plethysmography; a simple
and non-invasive method. Two strain gauges (D.E. Hokanson Inc., Bellevue, USA) were placed
above the ACB around the left and right calves. Measurements of the circumference of the
calves were conducted continuously throughout testing.
A standard tape measure and skinfold callipers (Slim GuideH, Creative Health Products,
Plymouth, USA) were used to measure the largest circumference of the calf and skinfold thick-
ness of the calf at its widest point. Measures were taken in triplicate on both legs, and the aver-
age was used for analysis.
Data analysis
Data are presented as the average of the first 20 seconds of the final 35 seconds before the
end of each test phase. For the ACB applied pressure, the average of the applied pressure on
the left and right legs are reported. Data from three participants (one female, two males) were
excluded from our analyses: one experienced presyncope during the protocol; one was unable
to tolerate ACB activation at the desired pressure; and in one the ACB was a poor fit to their
calves so desired pressures were not obtained. Strain gauge data (but not haemodynamic
responses) were excluded for one additional participant due to technical difficulties. Data from
one participant during HUT1 was excluded from the AUC calculation of SAP and SV since
the measurement was interrupted during the first few minutes of the phase.
Statistical analyses
All data were initially processed in MATLAB 2016Ra (The Mathworks Inc.) then transferred
to JMP 12.2.0 (Statistical Analysis Systems Institute Inc.) for statistical analyses. Data were
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tested for normality using the Kolmogorov and Smirnov assumption and parametric or non-
parametric testing used accordingly. Data are reported as means and standard error of mean.
Significance was considered where p<0.05. Comparisons for the main effects of condition
(ACB actuated or wrapped) and test phase (baseline, HUT 1, walk and HUT2) were conducted
using repeated measures of ANOVA, with the Tukey post hoc test. Interaction effects were
considered when the main effect was statistically significant. Multiple regression analyses were
used to develop a predictive model for efficacy of the ACB, change in SV and HR, from
selected anthropometric characteristics and ACB condition (wrapped or actuated). Two linear
regressions were conducted for the initial sudden change, and the delayed gradual change of
the calf circumference in HUT1. The intersection point was used to calculate separate contri-
bution of distension of capacitance vessels (pooling) and capillary filtration [17] in the volume
change of the calf.
Evaluation of ACB comfort and wearability
Wearability of a device can be affected in several ways, and should be taken into consideration
for the assessment of the device. These effects include physiological, comfort and biomechani-
cal factors [33] [33]. In this study, we used a questionnaire-based method to evaluate comfort
and wearability. Physiological effects were evaluated by participant self-assessment of the per-
ceived exertion of the device. Comfort was evaluated using the comfort rating scales (CRS)
proposed by Knight and Baber [34]. The CRS is explained briefly later in this section. Bio-
mechanical effects determine if a wearable device predisposes the wearer to excessive musculo-
skeletal or postural load [33]. In this study, as the ACB was designed to apply load on the body,
we only evaluated the compression exerted by the device on the calf as a marker of musculo-
skeletal loading; biomedical effects were excluded from our evaluation.
Descriptors of comfort. Several dimensions of comfort were considered encompassing
six domains: four domains of physical perceptions (domains 2, 3, 4 and 5), and two domains
of psychological perceptions (domains 1 and 6) of comfort. Domain-2 refers to nonharmful
sensations of the device on the body; domain-3 refers to the harm caused by the device con-
veyed through sensations of pain; domain-4 refers to nonharmful feelings associated with the
perception of being awkward, where the wearer makes conscious compensations or modifica-
tions to movements or actions; domain-5 refers to a direct impact of the device on normal
movement patterns; domain-1 refers to psychological perceptions of discomfort; domain-6
refers to concerns related to the safety of wearing the device and its performance [34]. Table 1
shows the questions related to the six comfort domains that were used in the questionnaires.
Each domain was assessed using a 21-point scale, called CRS, anchored at each end with the
labels “low” and “high”. A 21-point scale was used so that scoring on the scale would range
from 0 at the far left to 20 at the far right [34].” According to Knight and Baber this range was
considered large enough to elicit a range of responses that could be used for detailed analysis
and fulfilled the criterion of [35], which recommended the use of scales with 11 or more points
for subjective evaluation. In rating perceptions of comfort, each participant expressed his/her
level of agreement, from low to high, with the statements made in the “description” column of
Table 1. These statements were devised based on the interpretation of the aspect of comfort
each within each domain.
Criteria for wearability. We evaluated the wearability of the ACB based on the criteria
defined in Table 2. The level of effect ranging from low to extreme can be defined based on the
value recorded from the evaluation. Borg CR-10 and CRS scales were used for the descriptors
and the level of effect was categorised based on the value obtained, ranging from “low” to
“extreme”. Five wearability levels [33] were used as shown in Table 3.
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Results
Anthropometric measures
A summary of participant anthropometric measures and age is presented in Table 4.
ACB pressures applied
The ACB mean applied pressure, wrapped and actuated, for the four test phases are presented
in Fig 3A. The mean actuation pressures (the increase in the applied pressure due to ACB actu-
ation compared to the wrapped condition) were +12.6±1.5, +17.7±1.5, +20.7±1.7, and +16.7
±1.3 mmHg during the baseline, HUT1, walk, and HUT2 phases of the experiments respec-
tively (Fig 3A).
Calf volume changes
A representative example trace from one participant showing calf circumference changes
throughout testing can be seen in Fig 3B. In this individual, the circumference decreased -0.6
±0.0 cm during the baseline phase when the ACBs were actuated. Group data are shown in Fig
3C. For the group as a whole there was no significant difference in the calf circumference
between actuated and wrapped conditions. When we considered changes in calf circumference
due to venous pooling (initial rapid increase in circumference) and capillary filtration (second-
ary slow increase in circumference) separately, there were no significant main effects of actu-
ation on the responses obtained.
Cardiovascular responses
The impact of the actuation and wrapped conditions on cardiovascular responses during the
test phases can be seen in Table 5. In addition, the changes in SV, HR, CO, and TPR compared
to the baseline phase are illustrated in Fig 4.
Table 1. Questions for the CRSs evaluation [36].
Domain Question
Code
Description
(1) Emotions E-1 I was feeling worried about how I look when I wore the ACB.
I felt tense because I was wearing the ACB.
(2) Attachment A-1 I was not able to move as usual.
A-2 I had difficulty in putting on/off the device.
(3) Harm H-1 The attached ACB caused me some kind of harm.
(4) Perceived
change
Pc-1 Wearing the ACB made me feel physically different. I felt bulky.
(5) Movement M-1 The ACB affected the way I moved. The ACB inhibited or restricted
my movement.
(6) Anxiety An-1 I did not feel secure with the ACB.
An-2 I felt that I did not have the ACB properly attached.
An-3 I felt that the ACB was not working properly.
https://doi.org/10.1371/journal.pone.0187885.t001
Table 2. Level of effects and corresponding wearability levels [36].
Metric Units Level of Effect
Low Moderate Large Very Large Extreme
Energy cost Relative perceived exertion Borg CR-10 score 0–1 2–3 4–5 6–7 8–10
Comfort General wearability CRS score 0–4 5–8 9–12 13–16 17–20
https://doi.org/10.1371/journal.pone.0187885.t002
Evaluating the efficacy of an active compression brace on orthostatic cardiovascular responses
PLOS ONE | https://doi.org/10.1371/journal.pone.0187885 November 22, 2017 8 / 23
The effect of ACB actuation. There were significant main effects of test condition, i.e. the
difference between actuated and wrapped conditions, whereby the ΔSV (p = 0.008), and HR
(p = 0.007) were reduced with ACB actuation, and the pulse pressure was larger with ACB
actuation (p = 0.045) (Table 5). Because we were primarily interested in the impact of ACB
actuation during orthostasis, we examined the average change relative to baseline in SV and
HR during only the upright phases of HUT1, walk, and HUT2 (Fig 5A and 5B) as well as dur-
ing only the tilted phases (HUT1 and HUT2) (Fig 5C and 5D). There was a significant main
effect of test condition on HR change (p = 0.038) and borderline significant main effect of test
condition on SV change (p = 0.061), whereby they were reduced with ACB actuation during
HUT1, walk and HUT2 (Fig 5A and 5B). There was a significant main effect of test condition
on both SV change (p = 0.037) and HR change (p = 0.038), whereby they were reduced during
HUT1 and HUT2 (Fig 5C and 5D). When considering the differences between ACB actuation
and placebo during tilt after supine rest there were trends for a larger stroke volume (+5.20
±2.34%, p = 0.05) and lower heart rate (-5.12±2.41%, p = 0.06) with ACB actuation, with no
effect on systolic arterial pressure (+4.86±3.41%, p = 0.18). There were no significant differ-
ences in any other cardiovascular parameters between test conditions.
The cumulative AUC for SAP and SV are shown in Fig 6. There was a significant main
effect of test condition on SV AUC (p = 0.0011), where the SV AUC was smaller in the actu-
ated condition than the wrapped condition. When considering the interaction, the SV AUC
was significantly smaller in the actuated condition than the wrapped condition in HUT2
(p<0.05). There was no effect of test condition on the SAP AUC.
The effect of phase of testing. Significant main effects between test phases, i.e. the differ-
ences between baseline, HUT1, HUT2 and walking phases, can be seen in Fig 4. During the
walking phase, CO was significantly increased compared to baseline (ACB wrapped: +33.5
±4.2%; ACB actuated: +33.9±5.6%). TPR was significantly reduced in the walk phase com-
pared to baseline (ACB wrapped: -14.2±3.2%; ACB actuated: -12.4±4.9%). HR was increased
during walking compared to baseline (ACB wrapped: +32.5±3.7%; ACB actuated: +27.7
±3.6%). SV was not different during walking compared to baseline.
There was no significant effect of the two tilting phases on CO compared to baseline. SV
was significantly decreased during both HUT1 and HUT2 compared to baseline (ACB
Table 3. Level of effects and corresponding wearability levels [33].
Level of
Effect
Wearability
Level
Outcome
Low WL1 System is wearable
Moderate WL2 System is wearable, but changes may be necessary, further
investigation is needed
Large WL3 System is wearable, but changes are advised. Uncomfortable
Very Large WL4 System is not wearable, fatiguing, very uncomfortable
Extreme WPL5 System is not wearable, extremely stressful and potentially harmful
https://doi.org/10.1371/journal.pone.0187885.t003
Table 4. Mean and standard error of mean for anthropometric variables.
Age
(y)
Height
(cm)
Weight
(kg)
BMI
(kg/m2)
Right Calf
Circumference (cm)
Left Calf
Circumference (cm)
Muscle Cross
Sectional Area (cm2)
Skinfold Right Calf
Thickness (mm)
Skinfold Left
Calf
Thickness
(mm)
27.9
±1.3
172±2 68.6±1.9 23.2
±0.4
37.4±0.4 37.2±0.5 83.1±3.8 11.8±1.4 11.9±1.3
https://doi.org/10.1371/journal.pone.0187885.t004
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Fig 3. ACB performance and its impact on calf circumference changes. There was a significant main
effect of ACB activation on the calf pressures obtained difference (p<0.001) (A). A representative example
trace from one participant showing the impact of the ACB in wrapped and actuated conditions (B). Group data
(left and right legs combined) showing the impact on calf circumference in the two experimental conditions are
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wrapped: -23.9±2.8 and -27.9±3.8%; ACB actuated: -18.7±2.7 and -24.9±3.0% in HUT1 and
HUT2 respectively). HR was significantly increased during HUT1 and HUT2 compared to
baseline (ACB wrapped: +32.2±4.4 and +37.7±5.6%; ACB actuated: +27.0±4.6 and +31.1±5.5%
in HUT1 and HUT2 respectively. TPR increased significantly compared to baseline in both
HUT1 and HUT2 (ACB wrapped: +5.9±2.7 and +10.7±3.8%; ACB actuated: +7.6±4.1 and
+12.4±5.8%). When considering the cumulative AUC for SAP and SV (Fig 6.) there was a sig-
nificant main effect of test phase only for SAP AUC, where the AUC was larger (p = 0.016)
during HUT2 than HUT1.
Relationships between SV, HR change (%) and anthropometric variables. Considerable
variability was noted between individual responses for change in SV (%) and HR (%). We eval-
uated whether this was related to anthropometric variables. During HUT1, the change in SV
(%) was positively correlated with the height:calf circumference ratio (Fig 7A). The change in
HR (%) was positively correlated with the average calf circumference and was negatively corre-
lated with the height:calf circumference ratio (Fig 7B and 7C).
There was no significant relationship between the change in SV during HUT1 and the calf
circumference measurements when expressed as average calf circumference, muscle cross-
shown in (C). There was no significant difference in main effect of test actuation condition on calf
circumference.
https://doi.org/10.1371/journal.pone.0187885.g003
Table 5. Cardiovascular responses during baseline, HUT1 and HUT2 in the two ACB conditions.
Parameter Units ACB Phase
Baseline HUT1 HUT2
ΔCO l/min Wrapped - -0.02 ± 0.11 -0.15 ± 0.23
Actuated - 0.13 ± 0.18 -0.27 ± 0.23
* ΔSV ml Wrapped - -25 ± 3 × -29 ± 4
Actuated - -18 ± 2 -24 ± 2
SAP mmHg Wrapped 111 ± 4 112 ± 4 110 ± 6
Actuated 116 ± 5 123 ± 6 113 ± 5
DAP mmHg Wrapped 50 ± 2 55 ± 3 57 ± 4
Actuated 52 ± 2 59 ± 2 58 ± 2
MAP mmHg Wrapped 66 ± 2 70 ± 3 72 ± 4
Actuated 69± 3 75 ± 2 73 ± 2
* PP mmHg Wrapped 61 ± 2 58 ± 2 + × 53 ± 3
Actuated 64 ± 4 65 ± 5 56 ± 5
* HR beats/min Wrapped 64 ± 3 + 84 ± 3 88 ± 4
Actuated 71 ± 4 89 ± 4 92 ± 5
TPR mmHg.s/l Wrapped 0.622 ± 0.038 0.663 ± 0.048 + 0.698 ± 0.058
Actuated 0.615 ± 0.036 0.657 ± 0.038 0.683 ± 0.042
Data for SV and CO are shown as change relative to baseline values for each condition respectively. When considering the main effect of ACB actuation/
wrapped condition over the three phases, there were significant differences between actuated and wrapped conditions in ΔSV (p = 0.008), pulse pressure
(p = 0.045), and HR (p = 0.007). When considering the main effect of test phases for data collapsed according to ACB condition, there were significant
differences between baseline and HUT1 in HR (p<0.05), between baseline and HUT2 in pulse pressure and TPR (p<0.05), and between HUT1 and HUT2 in
ΔSV and pulse pressure (p<0.05). Abbreviations: CO, cardiac output; SV, stroke volume; SAP, systolic arterial pressure; DAP, diastolic arterial pressure;
MAP, mean arterial pressure; PP, pulse pressure; HR, heart rate; TPR, total peripheral resistance.
* denotes significant difference between actuated and wrapped conditions when considering the main effect of ACB over the three phases (p<0.05)
+ indicates denotes significant difference from baseline (p<0.05)
× denotes significant difference between HUT1 and HUT2 (p<0.05).
https://doi.org/10.1371/journal.pone.0187885.t005
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sectional area and height:muscle cross sectional area ratio. Similarly, there was no significant
relationship between the change in HR during HUT1 and the calf circumference measure-
ments when expressed as muscle cross-sectional areas and height:muscle cross sectional area
ratio. However, there was a significant relationship between the change in HR (%) and height:
calf circumference ratio (p = 0.022, R = -0.485); further analysis showed that average calf
Fig 4. SV, HR, CO and TPR changes in the two test conditions. There was a significant main effect of test condition on HR change (%)
(p = 0.038) and borderline significant main effect of test condition on SV change (%) (p = 0.061) during HUT1, walk and HUT2. Main effects of test
phase are indicated: * denotes significant difference from baseline (p<0.05); + denotes significant difference from walk (p<0.05).
https://doi.org/10.1371/journal.pone.0187885.g004
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Fig 5. Changes in SV and HR in the two conditions averaged over HUT1, walk and HUT2 combined (A & B) and averaged over the
two HUT tests only (C & D). There was a borderline significant main effect of test condition on SV change (p = 0.061) and significant main
effect of test condition on HR change (p = 0.038) during HUT1, walk and HUT2 (A, B). There was a significant main effect of test condition on
SV change (p = 0.037) and HR change (p = 0.038) when averaged during HUT1 and HUT2 only (C, D). Data are presented as the % change
relative to baseline. * denotes a significant difference for the actuation condition (p<0.05); double dagger (‡) indicates a borderline significant
difference (p = 0.061).
https://doi.org/10.1371/journal.pone.0187885.g005
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Fig 6. The cumulative area under the curve (AUC) during the different test phases in actuation and wrapped conditions.
The cumulative area under the curve (AUC) can be seen during each test phase for SV (A) and SAP (B). There was a significant
main effect of test condition (collapsed over the tilted phases) on SV AUC (p = 0.0011). Note the baseline shift in stroke volume in the
wrapped condition–highlighting the need to evaluate stroke volume responses as changes relative to baseline, rather than absolute
values, as described panels A and B, and in the manuscript. There was a significant main effect of test phase for SAP AUC, where
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circumference was negatively correlated to the height:calf circumference ratio (p = 0.015, R =
-0.512). These relationships between anthropometric characteristics and haemodynamic con-
trol were no longer significant when considered after the walking phase.
The ACB comfort and wearability evaluation
Physiological. Most participants did not feel the ACB was causing “exertion” in either
wrapped or actuated conditions (Fig 8). When the ACB was actuated, one female and two
male participants expressed physical stress. When the ACB was wrapped, two participants
expressed feelings of extra exertion.
Comfort. Results from the comfort evaluation can be seen in Fig 9.
Emotion. Fig 9A presents the participants responses to the questions related to emotion.
Most of the participants did not feel tense or worried about how they looked wearing the ACB.
Two of the females and one male participant had a moderate emotional concern.
Attachment. Most participants were unconcerned by the attachment of the ACB to their
body (Fig 9B and 9C). In terms of movement, two participants (one male and one female) felt
the device stopped them frommoving as usual and two participants (one male and one female)
reported they felt moderately uncomfortable. This feeling includes the sensation of having the
device on their bodies and its movement. Regarding the comfort in wearing the device, only
one female participant felt it was difficult to put on/off and one male participant was moder-
ately uncomfortable. Results show that attachment scored relatively higher for the female par-
ticipants compared to the males.
Harm. Results regarding any kind of harm such as pain, heat, itching, and irritation, caused
by the ACB are illustrated in Fig 9D. None of the female participants expressed any feeling of
being harmed, but there were two males who reported moderate to high concerns of harm.
Perceived change: The feedback from the participants on the perceived change is presented in
Fig 9E. One female participant expressed that the device felt “quite a lot” bulky. Also, there were
four other participants with moderate concern that the device felt bulky, twomales and two females.
Movement. The concerns of the participants in terms of movement restriction are
reflected in Fig 9F. Five participants (three males) expressed experiencing moderate obstruc-
tion of their movement when wearing the ACB. The rest of the participants did not show any
concerns regarding this aspect.
Anxiety. Answers to the questions related to anxiety arising because of wearing the ACB
are shown in Fig 9G,9H and 9I. None of the participants expressed any anxiety that the ACB
was not properly attached or was not working properly. One female participant felt moderately
insecure wearing the ACB.
Overall evaluation. The overall level of effect of the ACB on participants is summarized
in Table 6. It is observed that on average all the domains had a low level of effect. Target areas
for future improvement are perceived change and attachment, and to a lesser extent, harm and
movement.
Discussion
We have demonstrated that the prototyped ACB was effective at improving SV in a rando-
mised, double-blind, placebo-controlled study on healthy participants. The test protocol was
the AUC was larger during HUT2 than HUT1 (p = 0.0161). Example traces from a representative individual for SV and SAP in the
ACB wrapped and actuated conditions during phase HUT1 (C). Horizontal line indicates baseline SV and SAP for that individual and
shaded area indicates regions below supine SV and SAP. * denotes a significant difference (main effect) between the actuation and
wrapped conditions (p<0.05); + denotes significant difference (main effect) from HUT1 (p<0.05).
https://doi.org/10.1371/journal.pone.0187885.g006
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Fig 7. Relationships between SV, HR change (%) and anthropometric variables. Data are presented as
the % change relative to baseline.
https://doi.org/10.1371/journal.pone.0187885.g007
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designed to investigate the efficacy of the ACB during passive head-up tilting, in which blood
pooling occurs, and walking, in which the skeletal muscle pump increases venous return.
ACB pressures applied
The ACB can apply a desired wrapping compression similar to commercial compression
stockings, 15 mmHg, and when altering the compression by actuation, can apply pressure
up to 27.3±1.6 mmHg, in the supine resting position. In both HUT 1 and 2 phases applied
pressures showed a significant increase compared to the baseline phase (p<0.05). This
could be because of the muscle movements, contraction, and an increase in calf circumfer-
ence. The maximum applied pressure was observed in HUT1 and HUT2 phases when the
actuated ACB applied pressure of 46.3±2.2 and 44.8±2.1 mmHg respectively. The walk
phase showed lower applied pressure as a result of a drop in calf circumference. This
decrease could be because of an increase in venous return due to the muscle pump. It should
be mentioned that walking also altered the performance of the ACB due to increased heat
loss in the SMA wires. Walking increases the convective heat transfer coefficient because of
the air flow, which decreases the degree of actuation (phase transformation) in the SMA
wires. In fact, this alteration could potentially be useful as a self-regulatory factor of the
ACB since during walking, the muscle pump mechanism is active and there might be less of
a need for compression.
Calf volume changes
In both HUT1 and HUT2 phases there was an initial rapid and secondary gradual increase in
calf circumference that is thought to be due to venous pooling and capillary filtration respec-
tively [17]. In the walking phase, it was observed that the calf circumference decreased due to
muscle contractions and enhanced venous return. There were no significant differences in
Fig 8. The ACB wearability evaluation. Results for the perceived exertion evaluation with the ACB actuated (A) and the ACB
wrapped (B).
https://doi.org/10.1371/journal.pone.0187885.g008
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either calf volume changes, or changes attributed to venous pooling or capillary filtration,
between the actuated and wrapped conditions.
Fig 9. The ACB comfort evaluation. Comfort results are shown for each of the domains of emotion, attachment, harm, perceived change,
movement and anxiety. The participants were asked to rate their agreement with each of the following statements: “I was feeling worried about
how I look when I wore the ACB. I felt tense because I was wearing the ACB.” (A); “I was not able to move as usual.” (B); “I had difficulty in
putting on/off the device.” (C); “The attached ACB caused me some kind of harm.” (D); “Wearing the ACB made me feel physically different. I felt
bulky.” (E); “The ACB affected the way I moved. The ACB inhibited or restricted my movement.” (F); “I did not feel secure with the ACB.” (G); “I
felt that I did not have the ACB properly attached.” (H); and “I felt that the ACB was not working properly.” (I).
https://doi.org/10.1371/journal.pone.0187885.g009
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Cardiovascular responses
CO was maintained throughout each test, except during walking, when it increased markedly.
The maintenance of CO in the HUT1 and HUT2 phases likely reflects the intact baroreflex
response in these healthy control volunteers, whereby reductions in SV were accompanied by
compensatory increases in HR and vascular resistance. Indeed, the increases in HR during the
tilted phases closely matched the decreases in SV. This is compatible with a reduced venous
return when upright, secondary to venous pooling and plasma filtration [18], and a conse-
quence decrease in SV.
There were significant main effects of test condition on changes in SV and HR during tilt-
ing, whereby the SV was lower and HR higher in the wrapped than the actuated conditions.
This effect was less clear when the walking phase was incorporated, presumably because in this
case SV volume was mainly maintained because of the muscle pump mechanism and the
impact of device actuation was reduced. These data highlight the need for compression gar-
ment paradigms that can be applied selectively, only during passive orthostasis, and not during
active orthostatic manoeuvres such as walking when any deficits in cardiovascular reflex con-
trol may be offset by the action of the skeletal muscle pumps [37].
There was no significant effect of the actuation condition on blood pressure responses or
orthostatic burden (SAP AUC). This also likely reflects the intact baroreflex response in
healthy volunteers, in whom blood pressure is well maintained during brief mild orthostatic
stresses such as those encountered in the present study. However, the higher associated stroke
volume and lower heart rates during orthostatic stress in the actuation condition suggest that
this maintenance of blood pressure was achieved with a smaller baroreflex response, compati-
ble with the actuation condition augmenting stroke volume, and presumably, venous return.
When considering the possible relationships between SV, HR changes and anthropometric
variables we first examined interactions between the main conditions (ACB wrapped/actu-
ated) and each variable during initial passive orthostatic stress. Since we found no differences
in the slopes of these relationships between the two test conditions, we combined data for the
two ACB conditions. We showed that individuals with larger calf circumferences had higher
heart rate responses to orthostatic stress, associated with larger reductions in SV. Therefore, is
tempting to speculate that those with larger calf circumferences would be poised to benefit
most from ACB actuation; however, because there were no differences in the slopes between
the regressions for actuated and wrapped conditions, this is not the case. The relationships
between haemodynamic parameters and anthropometric variables were no longer signifi-
cant during the second tilt phase, which was preceded by walking. Presumably there is an
effect of walking and associated autonomic and muscle activation on either orthostatic hae-
modynamic control or calf circumference that persists for some time (at least ten minutes)
Table 6. Overall comfort and wearability evaluation results.
Metric Unit Score Level of Effect
Energy cost Perceived Exertion (ACB Actuated) Borg CR-10 score 0.68 ± 0.26 Low
Perceived Exertion (ACB Wrapped) Borg CR-10 score 0.64 ± 0.3 Low
Comfort Emotion CRS score 1.71 ± 0.74 Low
Attachment CRS score 3.11 ± 0.63 Low
Harm CRS score 2.36 ± 0.82 Low
Perceived change CRS score 3.21 ± 1.00 Low
Movement CRS score 2.79 ± 0.76 Low
Anxiety CRS score 0.57 ± 0.17 Low
https://doi.org/10.1371/journal.pone.0187885.t006
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after termination of the activity. This has implications for the use of the device during activ-
ities of daily living–device actuation may not be necessary during walking because the
enhanced skeletal muscle pumping and autonomic activity seem sufficient to maintain car-
diovascular control. We suggest that actuation of the device upon cessation of activity
would be of more benefit.
The ACB comfort and wearability
Overall the ACB comfort and wearability evaluation showed a low level of concern in all the
domains considered. Although overall the device was well tolerated, some participants
expressed discomfort, and priority areas for improvement in this regard were identified
(attachment and perceived change, and to a lesser extent, harm and movement).
Limitations
Our physiological tests were designed to be double-blind in the sense that the primary investi-
gator was unaware of the test condition during data collection and analysis, and the partici-
pants were not told what to expect from the compression conditions. However, although
participants were not informed whether the ACB was actuated or not on each test day, nor
were they told the expected outcome of the experiment, it is possible that the study was not
truly double-blinded. The ACB gets a bit warm when it is actuated, and participants may have
been aware of a different sensation due to the higher compression.
It is possible that we have underestimated the impact of ACB actuation, because we com-
pared it to a wrapped condition, which also applied a low level of pressure, and may itself have
reduced orthostatic fluid shifts and enhanced orthostatic cardiovascular control. Comparisons
of ACB actuation with no pressure application might show even greater benefit. However, we
wished to compare whether our device provided additional benefit over and above conven-
tional strategies that employ a low level of calf compression similar to our wrapped condition.
In addition, use of a wrapped condition had the benefit that for participants and experimenters
the protocol was the same for both tests, enhancing our ability to blind the study. Additional
considerations for future study might also include the incorporation of a true placebo condi-
tion in which no compression was applied.
We tested healthy volunteers, and we can not be certain if the results would extend similarly
to a patient population. For example, in healthy controls pooling and filtration is lower during
orthostatic stress than in patient populations [17], and so the potential to improve cardiovas-
cular control by ameliorating these effects might be expected to be reduced. However, we
believe our results may extend to patients with orthostatic intolerance, because a few of our
control participants actually showed high calf volume changes more comparable to those inpa-
tient populations. Furthermore, other non-pharmacological approaches to prevent or delay
syncope apply equally well to both patients and controls [38,39].
We had a relatively small sample size in this preliminary study proof-of-concept study, with
an obvious impact on statistical power. As a consequence, we only considered the main effects
of the test condition and phase, and not the interaction effects. Future studies should further
elucidate these interactions.
It may be that the application of compression stockings prior to rising in the morning
would have a greater effect, due to the ‘‘water jacket effect”, whereby oedema accumulating
during the day restricts further venous pooling [40]. However, it has been shown that 20 min-
utes of supine rest is sufficient to normalise any prior venous pooling/capillary filtration effect
[17], at least in control participants, so we consider this unlikely. The possibility for distal
oedema below the compression level should also be considered in future work.
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We evaluated the efficacy of the ACB on improvement of SV and calf volume changes, and
accordingly our results may not extend to other compression garments. The existing literature
suggests that compression garments extending to the thigh and abdomen may be more effec-
tive at preventing orthostatic intolerance [8,11,13,14], but are associated with poor patient sat-
isfaction and compliance [15,16]. Future studies may wish to examine the optimum
compromise between efficacy, comfort, and patient compliance.
Our limited sample size in this preliminary evaluation precluded the evaluation of potential
sex differences in terms of blood pooling and cardiovascular response to ACB actuation. Com-
parison between male and female participants’ responses and the efficacy of ACB should be
considered in future, particularly given the known differences in venous pooling and capillary
filtration between men and women [41] and increased susceptibility to orthostatic intolerance
in women [42].
Conclusions
This paper showed the feasibility of an ACB to achieve the desired external calf pressure, and
demonstrated an enhancement of stroke volume and reduction in orthostatic tachycardia dur-
ing device actuation. In addition, evidence was provided on wearability, comfort, viability and
ambulatory use of the ACB in human participants.
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